Lampropoulos Fred P's Form 4 filing
Merit Medical Systems Inc (MMSI) · filed Mar 6, 2025
- Accession no.
- 0001415889-25-007272
- Filed
- Mar 6, 2025
- Trade date
- Mar 5, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.56M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lampropoulos Fred PCIK 0000901534 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Common Stock, No Par Value | SSaleDisposed | −11,320 | $104.05 | −$1,177,846 | 1,106,028 | Direct | |
| Mar 5, 2025 | Common Stock, No Par Value | SSaleDisposed | −20,000 | $103.75 | −$2,075,000 | 1,086,028 | Direct | |
| Mar 5, 2025 | Common Stock, No Par Value | SSaleDisposed | −409.74 | $103.75 | −$42,510.53 | 10,324.26 | Indirect | |
| Mar 5, 2025 | Common Stock, No Par Value | SSaleDisposed | −2,590 | $103.75 | −$268,712.5 | 7,734.26 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.